Concepedia
Statistics
Publications
5
Citations
821
H-Index
Active since
1985
Affiliations
National Cancer Institute(Current)
National Institutes of Health
National Cancer Institute
John Edward McKnight is an author at National Cancer Institute specializing in oncology, pharmacology, and pharmacy.
Publications per year
1985–1990
A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia
Philip A. Pizzo, James W. Hathorn, John Hiemenz et al. · New England Journal of Medicine · 1986 · 593 citations
Pharmacy, Oncology, Pharmacotherapy +14
Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.
Ronald G. Steis, Walter J. Urba, Louis A. VanderMolen et al. · Journal of Clinical Oncology · 1990 · 106 citations
Medicine, Oncology, Pharmacology +11
Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen.
Jeffrey W. Clark, John W. Smith, Ronald G. Steis et al. · PubMed · 1990 · 54 citations
Pharmacy, Immunology, Oncology +12
Randomized trial of recombinant alpha 2b-interferon with or without indomethacin in patients with metastatic malignant melanoma.
Robin Lin Miller, Ronald G. Steis, Jeffrey W. Clark et al. · PubMed · 1989 · 38 citations
Medicine, Oncology, Pharmacology +12
New beta-lactam antibiotics in granulocytopenic patients: New options and new questions
Philip A. Pizzo, Michael Thaler, James W. Hathorn et al. · The American Journal of Medicine · 1985 · 30 citations
Pharmacy, Pharmacology, Pharmacotherapy +9
1–5 of 5